ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Permissions
Right arrowRequest Permissions
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Faughnan, M. E.
Right arrow Articles by Young, L. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Faughnan, M. E.
Right arrow Articles by Young, L. H.
Eur Respir J 2009; 33:1186-1194
Copyright ©ERS Journals Ltd 2009

The pulmonary vascular complications of hereditary haemorrhagic telangiectasia

M. E. Faughnan1,2, J. T. Granton3 and L. H. Young4

1 Keenan Research Centre and Li Ka Shing Knowledge Institute, St Michael's Hospital, 2 Dept of Medicine, Division of Respirology, St Michael’s Hospital, University of Toronto, and 3 Dept of Medicine, Division of Respirology, University Health Network, University of Toronto, Toronto, ON, Canada, 4 Dept of Medicine, Division of Cardiovascular Medicine, Yale Medical School, Yale University, New Haven, CT, USA.

CORRESPONDENCE: M. E. Faughnan, St Michael’s Hospital, 30 Bond Street, Toronto, ON, Canada, M5B-1W8. Fax: 1 4168645922. E-mail: faughnanm{at}smh.toronto.on.ca

Keywords: Hereditary haemorrhagic telangiectasia, pulmonary arterial hypertension, pulmonary arteriovenous malformation, pulmonary hypertension

Received: April 21, 2008
Accepted November 21, 2008

Hereditary haemorrhagic telangiectasia (HHT) is a rare autosomal dominant disorder, characterised by the presence of vascular malformations. The pulmonary vascular complications of HHT include pulmonary arteriovenous malformations, pulmonary hypertension associated with high-output heart failure and liver vascular malformations and, finally, pulmonary arterial hypertension secondary to HHT. In the present review, the authors describe the clinical presentation, diagnosis and management of all three pulmonary vascular presentations of HHT, as well as the underlying genetics and pathophysiology.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2009 by the European Respiratory Society.